Complex patients - complex DDI: is there a straight way forward?
Dealing with the complex drug–drug interactions: Towards mechanistic models
Proposal for defining the relevance of drug accumulation derived from single dose study data for modified release dosage forms
Population pharmacokinetics of etomidate in neonates and infants with congenital heart disease
Effects of hypertonic buffer composition on lymph node uptake and bioavailability of rituximab, after subcutaneous administration
Possible involvement of cationic-drug sensitive transport systems in the blood-to-brain influx and brain-to-blood efflux of amantadine across the blood–brain barrier